STOCKHOLDERS' EQUITY (Details 2) - Warrant [Member] |
3 Months Ended |
|---|---|
|
Dec. 31, 2015
USD ($)
$ / shares
shares
| |
| Class of Stock [Line Items] | |
| Number of Warrants, Outstanding | shares | 2,918,254 |
| Number of Warrants, Issued | shares | 0 |
| Number of Warrants, Exercised | shares | 0 |
| Number of Warrants, Expired | shares | (2,480,919) |
| Number of Warrants, Outstanding | shares | 437,335 |
| Number of Warrants, Exercisable | shares | 437,335 |
| Weighted Average Exercise Price, Outstanding | $ / shares | $ 0.89 |
| Weighted Average Exercise Price, Issued | $ / shares | 0 |
| Weighted Average Exercise Price, Exercised | $ / shares | 0 |
| Weighted Average Exercise Price, Expired | $ / shares | 1.00 |
| Weighted Average Exercise Price, Outstanding | $ / shares | 0.60 |
| Weighted Average Exercise Price, Exercisable | $ / shares | $ 0.60 |
| Weighted Average Remaining Life in Years, Outstanding | 2 months 1 day |
| Weighted Average Remaining Life in Years, Exercisable | 2 months 1 day |
| Intrinsic Value, Outstanding | $ | $ 0 |
| Intrinsic Value, Exercisable | $ | $ 0 |
| X | ||||||||||
- Definition The number of shares into which fully or partially vested non options equity instruments outstanding as of the balance sheet date. No definition available.
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the equity instruments reserved for issuance on vested portions of non options outstanding and currently exercisable. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the non option equity instruments reserved for issuance under the stock option plan. No definition available.
|
| X | ||||||||||
- Definition Amount of difference between fair value of the underlying equity instruments reserved for issuance and exercise price of vested portions of non options outstanding and currently exercisable. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which non option holders acquired awards when converting their non options equity instruments during the reporting period. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying equity instruments with respect to non options of the plan that expired. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire non option equity instruments by exercise of options. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of non options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Intrinsic value of equity-based compensation awards outstanding. Excludes stock and unit options. No definition available.
|
| X | ||||||||||
- Details
|